Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions

被引：8
|
作者：
Carlson, Geoffrey S. [1 ]
Wong, Priscilla H.
White, Kevin M. [2 ]
Quinn, James M. [1 ]
机构：
[1] Wilford Hall, Lackland AFB, TX USA
[2] Royal Air Force Lakenheath, Brandon, England
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2017年 / 5卷 / 05期
关键词：
VENOM; MEDICATION; SAFETY;
D O I：
10.1016/j.jaip.2017.05.009
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1430 / 1432
页数：3
相关论文
共 50 条
  • [1] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [2] ANTIPROTEINURIC AND RENOPROTECTIVE EFFECTS OF COMBINATION THERAPY WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND AN ANGIOTENSIN RECEPTOR BLOCKER
    Sadiku, Edita
    Idrizi, Alma
    Gjata, Margarita
    Barbullushi, Myftar
    Hoti, Klit
    Tase, Mihal
    Koroshi, Alketa
    NEPHROLOGY, 2005, 10 : A136 - A136
  • [3] Combined therapy with an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor in heart failure
    Struckman, DR
    Rivey, MP
    ANNALS OF PHARMACOTHERAPY, 2001, 35 (02) : 242 - 248
  • [4] COVID-19 and Angiotensin-Converting Enzyme Inhibitor/Angiotensin-Receptor Blocker Therapy
    Kussmaul, William G., III
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (03) : 237 - 238
  • [5] Paradoxical pressor response with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Sabitha, P.
    Adhikari, Prabha M.
    AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (07): : 364 - +
  • [6] THE ANTIPROTEINURIC EFFECT OF COMBINED ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN RECEPTOR BLOCKER THERAPY IN PRIMARY GLOMERULONEPHRITIS
    Kaptanogullari, Ozlem Harmankaya
    Ozbahar, Yalcin
    Cecen, Ismail
    Kaptanogullari, Hakan
    NEPHROLOGY, 2005, 10 : A168 - A168
  • [7] Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotection
    Hou, Fan Fan
    Zhou, Qiu Gen
    NEPHROLOGY, 2010, 15 : 57 - 60
  • [8] A CLINICAL EVALUATION OF HYPERKALAEMIA IN PATIENTS WITH RENAL IMPAIRMENT ON COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN-RECEPTOR BLOCKER
    Goh, T. H.
    Tan, S. C.
    Fook-Chong, S. M. C.
    Wong, K. S.
    Chan, C. M.
    NEPHROLOGY, 2005, 10 : A139 - A139
  • [9] Rationale for the use of combination angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker therapy in heart failure
    Carson, PE
    AMERICAN HEART JOURNAL, 2000, 140 (03) : 361 - 366
  • [10] Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin h receptor blocker therapy in heart failure
    Yasumura, Y
    Miyatake, K
    Okamoto, H
    Miyauchi, T
    Kawana, M
    Tsutamoto, T
    Kitakaze, M
    Matsubara, H
    Takaoka, H
    Anzai, T
    Himeno, H
    Yokoyama, H
    Yokoya, K
    Shintani, U
    Hashimoto, K
    Koretsune, Y
    Nakamura, Y
    Imai, K
    Maruyama, S
    Masaoka, Y
    Sekiya, M
    Shiraki, T
    Shinohara, H
    Ozono, K
    Matsuoka, T
    Miyao, Y
    Nomura, F
    CIRCULATION JOURNAL, 2004, 68 (04) : 361 - 366
12345